The recent challenges in global supply have highlighted the necessity of securing essential medications like Ivermectin. Relying on overseas manufacturers exposes countries to considerable vulnerabilities, including delivery delays, price fluctuations, and even geopolitical threats. Shifting towards domestic sourcing of Ivermectin offers a multitud